The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy

Coronavirus disease 2019 (COVID-19) was first officially described in Brazil on February 26th, 2020. The accumulation of reports of concomitant infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pathogens that cause diseases endemic to tropical countries, such as dengue...

Full description

Saved in:
Bibliographic Details
Published inRevista da Sociedade Brasileira de Medicina Tropical Vol. 53; p. e20200504
Main Authors Kurizky, Patricia Shu, Cerqueira, Selma Regina Penha Silva, Cunha, Débora Vilela, Albuquerque, Cleandro Pires de, Aires, Rodrigo Barbosa, Mota, Licia Maria Henrique da, Gomes, Ciro Martins
Format Journal Article
LanguageEnglish
Portuguese
Published Brazil Sociedade Brasileira de Medicina Tropical - SBMT 01.01.2020
Sociedade Brasileira de Medicina Tropical (SBMT)
Subjects
BCG Vaccine - administration & dosage
Betacoronavirus
Brazil
Case Report
Chagas disease
Chagas Disease - complications
Coinfections
Coronavirus Infections - complications
COVID-19
Family Characteristics
Humans
Leprosy
Leprosy, Borderline - complications
Pandemics
Pneumonia, Viral - complications
SARS-CoV-2
TROPICAL MEDICINE
Brazil
COVID-19
Leprosy
Chagas disease
Coinfections
Online AccessGet full text

Cover

More Information
Summary:Coronavirus disease 2019 (COVID-19) was first officially described in Brazil on February 26th, 2020. The accumulation of reports of concomitant infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pathogens that cause diseases endemic to tropical countries, such as dengue and chikungunya fever, has started to draw attention. Chagas disease and leprosy remain public health problems in many developing countries, such as Brazil. In this manuscript, we describe a case of concomitant leprosy, Chagas disease, and COVID-19, highlighting the cutaneous manifestations of SARS-CoV-2 infection and the clinical behavior of household contacts who previously received prophylactic Bacillus Calmette-Guérin vaccines.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Conflict of Interest: The authors declare that there is no conflict of interest.
Authors’ Contribution: PSK: data collection, data analysis and interpretation, drafted and critical revision of the article, approved final version of the article; SRPSC: data collection, drafted and critical revision of the article, approved final version of the article; DC: data collection, approved final version of the article; RMA: data analysis and interpretation, drafted and critical revision of the article, approved final version of the article; CPA: data collection, approved final version of the article; LMHM: data collection, data analysis and interpretation, drafted and critical revision of the article, approved final version of the article; CMG: data collection, data analysis and interpretation, drafted and critical revision of the article, approved final version of the article.
ISSN:0037-8682
1678-9849
1678-9849
DOI:10.1590/0037-8682-0504-2020